While there is speculation of where CBD regulations could be headed, no one knows for sure and it will largely depend on who replaces Gottlieb as the head of the FDA. (Photo: Shutterstock)
U.S. Food and Drug Administration Commissioner Dr. Scott Gottlieb's impending departure may push back long-awaited regulations on hemp and CBD, according to experts involved in those industries.
Rick Weissman, the president of hemp products maker High Falls Extracts, said Gottlieb, who announced Tuesday he will leave the FDA at the end of the month, supported hemp and CBD regulatory efforts.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Dan Clark
Dan covers cyber security, legal operations and intellectual property for Corporate Counsel. Follow him on Twitter @Danclarkalm.
